Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NITRIC for Pulmonary hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 551 adverse event reports in the FDA FAERS database where NITRIC was used for Pulmonary hypertension.

Most Reported Side Effects for NITRIC

Side Effect Reports % Deaths Hosp.
No adverse event 771 25.1% 0 0
Device malfunction 553 18.0% 2 0
Device issue 424 13.8% 21 0
Underdose 398 13.0% 3 0
Product use issue 332 10.8% 177 19
Death 314 10.2% 314 3
Drug ineffective 192 6.3% 65 135
Product use in unapproved indication 190 6.2% 119 12
Oxygen saturation decreased 169 5.5% 39 2
Off label use 166 5.4% 58 69
Condition aggravated 122 4.0% 65 19
Device delivery system issue 122 4.0% 2 0
Device failure 112 3.7% 8 0
Respiratory failure 79 2.6% 40 11
Covid-19 62 2.0% 59 4

Other Indications for NITRIC

Product used for unknown indication (876) Covid-19 (114) Newborn persistent pulmonary hypertension (96) Hypoxia (88) Acute respiratory distress syndrome (62) Respiratory failure (56) Pulmonary arterial hypertension (43) Persistent foetal circulation (31) Neonatal respiratory distress syndrome (22) Oxygen saturation decreased (19)

Other Drugs Used for Pulmonary hypertension

AMBRISENTAN (18,885) TREPROSTINIL (10,034) MACITENTAN (5,228) RIOCIGUAT (3,837) SILDENAFIL (3,761) SELEXIPAG (2,500) EPOPROSTENOL (2,486) TADALAFIL (2,430) BOSENTAN (2,337) ILOPROST (1,123)

Related Pages

NITRIC Full Profile All Pulmonary hypertension Drugs NITRIC Demographics NITRIC Timeline